[Skip to Navigation]
August 1990

Cutaneous Formation of Vitamin D in Psoriasis

Author Affiliations

Department of Dermatology Jefferson Medical College Philadelphia, PA 19107

Department of Medicine Southern Illinois University School of Medicine Springfield, IL 62701

Department of Medicine University of Pennsylvania School of Medicine Philadelphia, PA 19104

Department of Pediatrics Medical University of South Carolina Charleston, SC 29425

Arch Dermatol. 1990;126(8):1107-1108. doi:10.1001/archderm.1990.01670320131033

To the Editor.—  Vitamin D action requires epidermal synthesis (interaction of ultraviolet light B [UV-B] photons and 7-dehydrocholesterol molecules) and systemic activation in the liver and kidneys (to 25-dihydroxyvitamin D [25-OH-D] and 1,25-dihydroxyvitamin D [1,25-(OH)2-D]). A subtle or minimal impairment of this process was evaluated in the present study of patients with psoriasis of varying extent. The rationale for the investigation was (1) psoriasis is an epidermal disorder, and (2) psoriasis has been treated with the active vitamin D metabolite 1,25-(OH)2-D.1,2

Materials and Methods.—  The study population was composed of 11 patients with psoriasis and 11 control subjects. Patients with psoriasis consisted of six men and five women with a mean age of 34 years (range, 25 to 69 years). Ten subjects were white and one was East Asian (Oriental). All had histologically confirmed psoriasis. At the time of the study, 10 of the patients

Add or change institution